Breaking News
Scientists at Ohio State University have created an antibody that was successful in protecting a majority of the tested mice from lethal influenza (flu) doses, even preventing some from experiencing any symptoms at all.
Roche’s novel antibiotic zosurabalpin is entering Phase III testing to determine its effectiveness in protecting against carbapenem-resistant Acinetobacter baumannii (CRAB), am antimicrobial resistance (AMR) drug, or “superbug,” that is considered an “urgent threat” by the Centers for Disease Control and Prevention (CDC).
The U.S. Food and Drug Administration has given marketing clearance to the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, a blood test to help diagnose Alzheimer’s disease for adults 55 and older who are showing signs and symptoms of the disease. It is the first test to be approved to aid in the early detection of the disease in the United States.
BioTrending
- By Trudie Mitschang
When it comes to online health information, the Internet is a place where falsehoods flourish. Combating questionable content is no easy task, requiring education, legislation and diligence from stakeholders in the healthcare, scientific and public health communities.
- By Meredith Whitmore
Your words, tone and body language can escalate patient fears, but they also have the power to ease anxiety and help patients cope.
- By Jim Trageser
Though mostly eradicated in the U.S., treatment for rabies must begin immediately with hyperimmune globulin and vaccines.
- By Keith Berman, MPH, MBA
With 16 FVIII products now approved for the treatment of hemophilia A, many patients with this disease are now able to live a normal life.
Awards
BSTQ is an Industry Award-Winning Journal
Since its debut in 2009, BioSupply Trends Quarterly’s articles have been recognized by some of the industry’s most prominent organizations, earning platinum and gold awards.
